A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer
Clinical trial NCT00819754 · TERMINATED
Trial details
- NCT number
- NCT00819754
- Sponsor
- Ottawa Hospital Research Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2012-02-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.